Suppr超能文献

安非他酮与氯氮平联用:联合用药后癫痫发作的病例报告

Bupropion With Clozapine: Case Reports of Seizure After Coadministration.

作者信息

Schmitz Allison, Botner Brandon, Hund Morris

机构信息

Pharmacy Department, 20057Fargo VA Health Care System, ND, USA.

Mental Health Department, 20057Fargo VA Health Care System, ND, USA.

出版信息

J Pharm Pract. 2021 Jun;34(3):497-502. doi: 10.1177/0897190020904280. Epub 2020 Feb 21.

Abstract

BACKGROUND

Clozapine is more effective than other atypical antipsychotics for treatment resistant schizophrenia, but has serious side effects. Clozapine has an estimated cumulative seizure risk of 10% in patients treated for 3.8 years. Bupropion can also induce seizures and its estimated risk is 0.4% at recommended doses. While some risk factors for seizures are known, much remains unknown about predicting seizure risk. We present 2 cases of seizures in patients treated with clozapine and bupropion without a seizure history. In the first case, a patient with schizoaffective disorder treated with dual antipsychotic therapy had a witnessed generalized tonic-clonic seizure. With the exception of bupropion/naltrexone which was started 2.5 months prior for weight loss, she had not had any recent medication changes. In the second case, a patient with schizoaffective disorder was treated with clozapine and was prescribed bupropion SR for smoking cessation for an extended duration. He had cut back on cigarette use in the 2 months prior to reporting "spells." The neurologist's assessment was probable epileptic seizures which resolved after the bupropion was stopped and divalproex was started for seizure prophylaxis.

CONCLUSION

Clozapine and bupropion are known to lower the seizure threshold, but little information is available regarding the risk when used in combination. It is unclear whether these agents, when used in combination, have additive seizure risk or possible synergistic effects. Bupropion should be used cautiously in patients treated with clozapine. Safer agents that do not lower the seizure threshold should be utilized whenever possible.

摘要

背景

氯氮平治疗难治性精神分裂症比其他非典型抗精神病药物更有效,但有严重的副作用。接受治疗3.8年的患者中,氯氮平导致癫痫发作的累计风险估计为10%。安非他酮也可诱发癫痫发作,在推荐剂量下其估计风险为0.4%。虽然已知一些癫痫发作的风险因素,但关于预测癫痫发作风险仍有很多未知之处。我们报告2例在使用氯氮平和安非他酮治疗且无癫痫发作史的患者中出现癫痫发作的病例。在第一个病例中,一名接受双重抗精神病药物治疗的分裂情感性障碍患者出现了一次全身性强直阵挛发作。除了2.5个月前开始用于减肥的安非他酮/纳曲酮外,她近期没有任何用药变化。在第二个病例中,一名分裂情感性障碍患者接受氯氮平治疗,并长期服用缓释安非他酮以戒烟。在报告“发作”前的2个月里,他减少了吸烟量。神经科医生评估可能为癫痫发作,在停用安非他酮并开始使用丙戊酸预防癫痫发作后症状缓解。

结论

已知氯氮平和安非他酮会降低癫痫发作阈值,但关于联合使用时的风险信息很少。尚不清楚这些药物联合使用时是否具有相加的癫痫发作风险或可能的协同作用。在接受氯氮平治疗的患者中应谨慎使用安非他酮。应尽可能使用不降低癫痫发作阈值的更安全药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验